...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: How & who comes up with valuations?

Are the numbers derived from what they feel the fair market value of company is at the time the PP's  etc etc are done? Who decides that & is there any oversight etc?

they seem cheap, almost like gifts to the insiders etc participating. 

Would people doing this be privileged with/to more information than what we see or do they only know/see the same information that we have been presented with?

I just don't understand how they could be privey to insider information that we are not should that be the case?

Share
New Message
Please login to post a reply